Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

Presentation TCT 2024

TCT 599: The Prognostic Role of a Novel Computational Approach Assessing Microcirculatory Resistance Based on a Single Angiographic View in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Yang Chen

October 29, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Opinion Editor's Corner

The Biggest News of 2023: TCTMD’s Top 10

Shelley Wood

January 01, 2024

Advertisement

December 2024 Dispatch for the CV Team

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

TCT 599: The Prognostic Role of a Novel Computational Approach Assessing Microcirculatory Resistance Based on a Single Angiographic View in Patients Undergoing Transcatheter Aortic Valve Replacement

What’s Going to Be Big at TCT 2024?

August 2024 Dispatch for the CV Team

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

January 2024 Dispatch for the CV Team

The Biggest News of 2023: TCTMD’s Top 10

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content